Turnstone Biologics Corp. Common Stock (TSBX) — Financial Flexibility Index
Turnstone Biologics Corp. Common Stock (TSBX) has a Financial Flexibility Index of -0.68x as of June 2025. Free cash flow of $-4.30 Million (operating CF $-4.30 Million minus capex $0.00) represents -1% of total liabilities ($6.34 Million). Check tangible net worth ratio of Turnstone Biologics Corp. Common Stock to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Turnstone Biologics Corp. Common Stock Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for Turnstone Biologics Corp. Common Stock across 4 annual periods. For the full cash flow conversion analysis, see Turnstone Biologics Corp. Common Stock cash flow conversion.
Annual Financial Flexibility Index for Turnstone Biologics Corp. Common Stock (2021–2024)
Year-by-year free cash flow to debt coverage for Turnstone Biologics Corp. Common Stock. Explore TSBX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -7.75x | $-67.21 Million | $-67.44 Million | $8.67 Million | ▼ -68.9% |
| 2023 | -4.59x | $-64.90 Million | $-66.15 Million | $14.15 Million | ▼ -1406.6% |
| 2022 | -0.30x | $-65.89 Million | $-71.06 Million | $216.41 Million | ▼ -94.1% |
| 2021 | -0.16x | $-42.22 Million | $-45.63 Million | $269.10 Million | — |